Skip to main content
SpringerLink
Log in

Urinary proteins in multiple myeloma: correlation with clinical parameters and diagnostic implications

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Renal failure is one of the worst complications occurring in multiple myeloma (MM) patients. It does not affect survival if reverted by a prompt chemotherapy before the damage becomes irreversible; therefore, the early diagnosis of renal dysfunction is crucial. High and low molecular weight urinary proteins have proved to be helpful in diagnosing initial renal damage since they are more sensitive than urea and creatinine serum levels or creatinine clearance. We studied the renal function of 111 MM patients through serum creatinine, urea, urinary IgG, α1-microglobulin (α1-M), and albumin (Alb). Two successive controls were made in a subset of 30 patients, categorized in three groups (improved, stable, worsened) according to the behavior of tumor burden markers (bone marrow plasmacytosis, monoclonal component, and β2-microglobulin). In every group, we evaluated the behavior of urinary proteins. Renal dysfunction evaluated with serum parameters was present in 19 patients (17%), while if studied with urinary proteins was revealed in 71 patients (64.5%). Urinary proteins statistically correlated with each other. They correlated with creatinine, IgG, and α1-M also with urea. By contrast, they showed a variable correlation with clinical parameters: α1-M correlated with bone marrow plasmacytosis (BMPC) (p=0.02) and β2-M (p=0.000001), IgG with all three disease parameters (MC p=0.0005, BMPC p=0.009, β2-M p=0.007), and Alb only with β2-M (p=0.0004). In the subset of 30 patients followed with two successive controls, urinary proteins showed a parallel behavior with the indices of tumor burden. In conclusion, IgG, α1-microglobulin, and albumin are reliable and sensitive to precociously reveal renal damage, and we recommend their routine use for the definition and monitoring of renal function in multiple myeloma patients, mainly those in early stage, to better identify initial signs of progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.

Similar content being viewed by others

References

  1. Bernstein SP, Humes ND (1982) Reversible renal insufficiency in multiple myeloma. Arch Intern Med 142:2083–2086

    Article  CAS  PubMed  Google Scholar 

  2. Alexanian R, Barlogie B, Dixon D (1990) Renal failure in multiple myeloma. Pathogenesis and prognostic implications. Arch Intern Med 150:1693–1695

    Article  CAS  PubMed  Google Scholar 

  3. Kyle RA (1975) Multiple myeloma. Review of 869 cases. Mayo Clin Proc 50:29–40

    CAS  PubMed  Google Scholar 

  4. Bladè J, Fernandez-Llama P, Bosch F, Montoliu J, Lens XM, Montoto S, Cases A, Darnell D, Rozman C, Montserrat E (1998) Renal failure in multiple myeloma. Presenting features and predictors of outcome in 94 patients from a single institution. Arch Intern Med 158:1889–1893

    Article  PubMed  Google Scholar 

  5. Sakhuja V, Vivekanand J, Subhash V, Joshi K, Gupta KL, Sud K, Kohli HS (2000) Renal involvement in multiple myeloma: a 10-year study. Ren Fail 22:465–477

    Article  CAS  PubMed  Google Scholar 

  6. Tricot G, Alberts DS, Johnson CH, Roe DJ, Dorr RT, Bracy D, Vesole DH, Jagannath S, Meyers R, Barlogie B (1996) Safety of autotransplants with high dose melphalan in renal failure: a pharmacokinetic study. Clin Cancer Res 2:947

    CAS  PubMed  Google Scholar 

  7. Rebibou JM, Caillot D, Casasnovas RO, Tanter Y, Maillard N, Solary E, Rifle G, Guy H (1997) Peripheral blood stem cell transplantation in a multiple myeloma patient with end-stage renal failure. Bone Marrow Transplant 20:63–65

    Article  CAS  PubMed  Google Scholar 

  8. Ballester OF, Tummala R, Janssen WE, Fields KK, Hiemenz JW, Goldstein SC, Perkins JB, Sullivan DM, Rosen R, Sackstein R, Zorsky P, Saez R, Elfenbein GJ (1997) High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency. Bone Marrow Transplant 20:653–656

    Article  CAS  PubMed  Google Scholar 

  9. Tosi P, Zamagni E, Ronconi S, Benni M, Motta MR, Rizzi S, Tura S, Cavo M (2000) Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure. Leukemia 14:1310–1313

    Article  CAS  PubMed  Google Scholar 

  10. Sirohi B, Powles R, Mehta J, Treleaven J, Raje N, Kulkarni S, Rudin C, Bhagwati N, Horton C, Saso R, Singhal S, Parikh P (2001) The implication of compromised renal function at presentation in myeloma. Med Oncol 18:39–50

    Article  CAS  PubMed  Google Scholar 

  11. San Miguel JF, Lahuerta JJ, Garcia-Sanz R, Alegre A, Bladé J, Martinez R, et aGarcia-larana J, De la Rubia J, Sureda A, Vidai MJ, Escudero A, Pérez-Esquiza E, Conde E, Garcìa Ruiz JC, Cabrera R, Caballero D, Moraleda JM, Leòn A, Besalduch J, Hernàndez F, Solano C, Palomera L, Parody R, Gonzàlez JD, Mataix R, Maldonado J, Constela J, Carrera D, Bello JL, De Pablos JM, Pèrez-Simòn JA, Torres JP, Olanguren J, Prieto E, Acebede G, Penarubbia MJ, Torres P, Diez-Martin JL, Rivas A, Sànchez LM, Diaz-Mediavilla J (2000) Are myeloma patients with renal failure candidates for autologous stem cell transplantation? Hematol J 1:28–36

  12. Shemesh O, Golbetz H, Kriss JP, Myers BD (1985) Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 28:830–838

    Article  CAS  PubMed  Google Scholar 

  13. Weber MH, Verwiebe R (1992) A1 microglobulin (protein HC) features of promising indicator of proximal tubular dysfunction. Eur J Clin Chem Clin Biochem 30:683–691

    CAS  PubMed  Google Scholar 

  14. Honkanen E, Pettersson T, Teppo AM (1995) Urinary α1 and β2 microglobulin in light chain proteinuria. Clin Nephrol 44:22–27

    CAS  PubMed  Google Scholar 

  15. Corso A, Serricchio G, Zappasodi P, Klersy C, Bosoni T, Moratti R, Castagnola C, Lazzarino M, Pagnucco G, Bernasconi C (1999) Assessment of renal function in patients with multiple myeloma: the role of urinary proteins. Ann Hematol 78:371–375

    Article  CAS  PubMed  Google Scholar 

  16. Zappasodi P, Pascutto C, Bosoni T, Corso A (2001) Urinary proteins in multiple myeloma: strong correlation with the indices of tumor burden. Haematologica 86:878

    CAS  PubMed  Google Scholar 

  17. Chronic Leukemia-Myeloma Task Force (1973) Proposed guidelines for clinical studies. Cancer Chemother Rep 4:145–158

    Google Scholar 

  18. Durie GBM, Salmon SE (1975) A clinical staging system for multiple myeloma. Cancer 36:842–854

    Article  CAS  PubMed  Google Scholar 

  19. Knudsen LM, Hippe E, Hjoprth M, Holmberg E, Westin J (1994) Renal function in newly diagnosed multiple myeloma—a demographic study of 1353 patients. Eur J Haematol 53:207–221

    Article  CAS  PubMed  Google Scholar 

  20. Rota S, Mougenot B, Baudoin B, Mignon F, Rondeau E, Vanhille P, Verroust P (1987) Multiple myeloma and severe renal failure: a clinicopathologic study of outcome and prognosis in 34 patients. Medicine (Baltimore) 66:126–137

    Article  CAS  Google Scholar 

  21. Pasquali S, Zucchelli P, Casanova S, Cagnoli L, Confalonieri R, Pozzi C, Banfi G, Lupo A, Bertani T (1987) Renal histological lesions and clinical syndromes in multiple myeloma. Clin Nephrol 27:222–228

    CAS  PubMed  Google Scholar 

  22. Bazzi C, Petrini C, Rizza V, Arrigo G, Beltrame A, Pisano L, D'Amico G (2001) Urinary excretion of IgG and α1-microglobulin predicts clinical course better than extent of proteinuria in membranous nephropathy. Am J Kidney Dis 38:240–248

    Article  CAS  PubMed  Google Scholar 

  23. Yu H, Yanagisawa Y, Forbes MA, Cooper EH, Crockson RA, Mac Lennan ICM (1983) Alpha-1-microglobulin: an indicator protein for renal tubular function. J Clin Pathol 36:253–259

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Hematology, IRCCS Policlinico San Matteo, University of Pavia, 27100, Pavia, Italy

    A. Corso, P. Zappasodi, C. Pascutto, S. Mangiacavalli, A. Lorenzi, C. Rusconi & M. Lazzarino

  2. Department of Biochemistry, Policlinico San Matteo, University of Pavia, Pavia, Italy

    T. Bosoni

Authors
  1. A. Corso
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Zappasodi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Pascutto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. Bosoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Mangiacavalli
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Lorenzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. C. Rusconi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M. Lazzarino
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Corso.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Corso, A., Zappasodi, P., Pascutto, C. et al. Urinary proteins in multiple myeloma: correlation with clinical parameters and diagnostic implications. Ann Hematol 82, 487–491 (2003). https://doi.org/10.1007/s00277-003-0699-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-003-0699-9

Keywords

Search

Navigation